tiprankstipranks
Trending News
More News >
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market

Guided Therapeutics (GTHP) Income Statement

Compare
26 Followers

Guided Therapeutics Income Statement

Last quarter (Q3 2025), Guided Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Guided Therapeutics's net income was $-785.00K. See Guided Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 7.00K$ 98.00K$ 13.00K$ 81.00K$ 102.00K
Gross Profit
$ 2.00K$ 36.00K$ -68.00K$ 20.00K$ 143.00K
Operating Expenses
$ 2.11M$ 3.49M$ 3.27M$ 2.38M$ 1.20M
Depreciation and Amortization
$ 95.00K$ 85.00K$ 72.00K$ 1.00K$ 21.00K
EBITDA
$ -1.94M$ -3.13M$ -3.69M$ -919.00K$ 798.00K
Operating Income
$ -2.11M$ -3.46M$ -3.33M$ -2.36M$ -1.05M
Other Income/Expenses
$ -309.00K$ -32.00K$ -1.01M$ 292.00K$ 773.00K
Pretax Income
$ -2.42M$ -3.49M$ -4.34M$ -2.07M$ -279.00K
Net Income
$ -2.42M$ -3.49M$ -4.34M$ -2.07M$ -279.00K
Per Share Metrics
Basic EPS
$ -0.05$ -0.07$ -0.15$ -0.18$ -0.04
Diluted EPS
$ -0.05$ -0.07$ -0.15$ -0.18$ -0.04
Weighted Average Shares Outstanding
57.34M 51.13M 32.51M 13.38M 10.77M
Weighted Average Shares Outstanding (Diluted)
57.34M 51.13M 32.51M 13.38M 10.77M
Currency in USD

Guided Therapeutics Earnings and Revenue History